Mediar will receive a combined $99m consisting of an upfront payment and near-term milestones.
Mediar Therapeutics signs licensing deal with Eli Lilly for IPF treatment
January 13, 2025
Mediar will receive a combined $99m consisting of an upfront payment and near-term milestones.